Connect Sign In
Discover the latest research from ARUP scientists and learn from challenging genetics case studies while exploring the molecular pathology techniques used in the cases’ ultimate diagnoses.
ARUP has completed a CDC-funded metagenomic sequencing project that strengthens emerging pathogen surveillance and lays the groundwork for future infectious disease testing.
Discover how ARUP is advancing pediatric care through innovations in genomics, infectious disease, allergen testing, and more at the AAP 2026 National Conference.
During Newborn Screening Awareness Month, explore updated ARUP Consult® resources that support follow-up testing and diagnosis for conditions identified through newborn screening.
ARUP pairs analytical rigor with specialty expertise in immunopathology to provide reliable results, insights, and answers to complex diagnostic questions. Explore solutions with us at AMLI 2026.
ARUP CLARISPECT™ Multiple Myeloma MRD by Spectral Flow Cytometry characterizes neoplastic populations with greater confidence and sensitivity, while minimizing specimen volume requirements.
Discover how ARUP is advancing laboratory medicine at ADLM 2026 through research presentations, expert insights, and innovative diagnostic solutions.
Cyclosporiasis cases are on the rise. ARUP’s AI-enhanced parasite screening offers greater sensitivity to detect Cyclospora and supports outbreak response efforts.
Tick activity has traditionally peaked during the warmer months but that seasonal window appears to be expanding. Changing climate patterns resulting in milder winters are allowing more ticks to survive, contributing to earlier emergence in the spring.
ARUP has launched multiplex polymerase chain reaction bacterial gastrointestinal panels that detect common pathogens with faster turnaround times to support rapid diagnosis and public health response.
